SANDRA KELLETT: Open Payments
NPI 1396860169 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 31 payments from 15 companies in 2025. Trend: 2023 $374 · 2024 $359 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $224 |
| HISTOSONICS, INC. | 1 | $97 |
| GENZYME CORPORATION | 3 | $86 |
| Janssen Biotech, Inc. | 3 | $74 |
| Merit Medical Systems Inc | 1 | $69 |
| Madrigal Pharmaceuticals | 2 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| PFIZER INC. | 2 | $44 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
Products named: LINZESS, DUPIXENT, TREMFYA, ESOPHYX, REZDIFFRA, XELJANZ, SKYRIZI, ZENPEP.
Industry payments across AZ — which companies pay providers there.
